Phoenix BioPower has raised 4.4 MSEK in funding from a group of 147 shareholders.
The funding was executed during March and April and will provide the company vital funding for the development effort of the BTC technology.
For more information, please contact CEO Henrik Båge, henrik.bage @ pheonixbiopower.com
